{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T23:10:27Z","timestamp":1733526627317,"version":"3.30.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,6]]},"DOI":"10.7759\/cureus.75236","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T22:36:05Z","timestamp":1733524565000},"source":"Crossref","is-referenced-by-count":0,"title":["Indoxyl Sulfate and Its Potential Role in Mineralocorticoid Receptor Transactivation in Chronic Kidney Disease"],"prefix":"10.7759","author":[{"given":"Akiko","family":"Kudo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koro","family":"Gotoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Bikbov B","year":"2020","unstructured":"Bikbov B, Purcell C, Levey AS, et al.. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020, 395:709-33. 10.1016\/S0140-6736(20)30045-3","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2542-5196(24)00026-3","article-title":"Ambient heat exposure and kidney function in patients with chronic kidney disease: a post-hoc analysis of the DAPA-CKD trial","volume":"8","author":"Zhang Z","year":"2024","unstructured":"Zhang Z, Heerspink HJL, Chertow GM, et al.. Ambient heat exposure and kidney function in patients with chronic kidney disease: a post-hoc analysis of the DAPA-CKD trial. Lancet Planet Health. 2024, 8:225-33. 10.1016\/S2542-5196(24)00026-3","journal-title":"Lancet Planet Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108448","article-title":"Podocyte injury caused by indoxyl sulfate, a uremic toxin and aryl-hydrocarbon receptor ligand","volume":"9","author":"Ichii O","year":"2014","unstructured":"Ichii O, Otsuka-Kanazawa S, Nakamura T, et al.. Podocyte injury caused by indoxyl sulfate, a uremic toxin and aryl-hydrocarbon receptor ligand. PLoS One. 2014, 9:e108448. 10.1371\/journal.pone.0108448","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.15195","article-title":"Indoxyl sulfate enhance the hypermethylation of klotho and promote the process of vascular calcification in chronic kidney disease","volume":"12","author":"Chen J","year":"2016","unstructured":"Chen J, Zhang X, Zhang H, et al.. Indoxyl sulfate enhance the hypermethylation of klotho and promote the process of vascular calcification in chronic kidney disease. Int J Biol Sci. 2016, 12:1236-46. 10.7150\/ijbs.15195","journal-title":"Int J Biol Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5551\/jat.34462","article-title":"Crucial role of the aryl hydrocarbon receptor (AhR) in indoxyl sulfate-induced vascular inflammation","volume":"23","author":"Ito S","year":"2016","unstructured":"Ito S, Osaka M, Edamatsu T, Itoh Y, Yoshida M. Crucial role of the aryl hydrocarbon receptor (AhR) in indoxyl sulfate-induced vascular inflammation. J Atheroscler Thromb. 2016, 23:960-75. 10.5551\/jat.34462","journal-title":"J Atheroscler Thromb"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002023","article-title":"Role of indoxyl sulfate as a predisposing factor for atrial fibrillation in renal dysfunction","volume":"4","author":"Aoki K","year":"2015","unstructured":"Aoki K, Teshima Y, Kondo H, et al.. Role of indoxyl sulfate as a predisposing factor for atrial fibrillation in renal dysfunction. J Am Heart Assoc. 2015, 4:e002023. 10.1161\/JAHA.115.002023","journal-title":"J Am Heart Assoc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink HJ","year":"2020","unstructured":"Heerspink HJ, Stef\u00e1nsson BV, Correa-Rotter R, et al.. Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020, 383:1436-46. 10.1056\/NEJMoa2024816","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2022020207","article-title":"Albuminuria-lowering effect of dapagliflozin, eplerenone, and their combination in patients with chronic kidney disease: A randomized cross-over clinical trial","volume":"33","author":"Provenzano M","year":"2022","unstructured":"Provenzano M, Puchades MJ, Garofalo C, et al.. Albuminuria-lowering effect of dapagliflozin, eplerenone, and their combination in patients with chronic kidney disease: A randomized cross-over clinical trial. J Am Soc Nephrol. 2022, 33:1569-80. 10.1681\/ASN.2022020207","journal-title":"J Am Soc Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2011.245","article-title":"Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension","volume":"25","author":"Shibata H","year":"2012","unstructured":"Shibata H, Itoh H. Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension. Am J Hypertens. 2012, 25:514-23. 10.1038\/ajh.2011.245","journal-title":"Am J Hypertens"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08383-2","article-title":"A novel aldosterone antagonist limits renal injury in 5\/6 nephrectomy","volume":"7","author":"Fujihara CK","year":"2017","unstructured":"Fujihara CK, Kowala MC, Breyer MD, et al.. A novel aldosterone antagonist limits renal injury in 5\/6 nephrectomy. Sci Rep. 2017, 7:7899. 10.1038\/s41598-017-08383-2","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2131\/jts.39.637","article-title":"Indoxyl sulfate induces renin release and apoptosis of kidney mesangial cells","volume":"39","author":"Wang WJ","year":"2014","unstructured":"Wang WJ, Cheng MH, Sun MF, Hsu SF, Weng CS. Indoxyl sulfate induces renin release and apoptosis of kidney mesangial cells. J Toxicol Sci. 2014, 39:637-43. 10.2131\/jts.39.637","journal-title":"J Toxicol Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034026","article-title":"Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition","volume":"7","author":"Sun CY","year":"2012","unstructured":"Sun CY, Chang SC, Wu MS. Uremic toxins induce kidney fibrosis by activating intrarenal renin-angiotensin-aldosterone system associated epithelial-to-mesenchymal transition. PLoS One. 2012, 7:e34026. 10.1371\/journal.pone.0034026","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M607741200","article-title":"Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9","volume":"282","author":"Yokota K","year":"2007","unstructured":"Yokota K, Shibata H, Kurihara I, et al.. Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9. J Biol Chem. 2007, 282:1998-2010. 10.1074\/jbc.M607741200","journal-title":"J Biol Chem"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.16-649","article-title":"High glucose stimulates mineralocorticoid receptor transcriptional activity through the protein kinase C \u03b2 signaling","volume":"58","author":"Hayashi T","year":"2017","unstructured":"Hayashi T, Shibata H, Kurihara I, et al.. High glucose stimulates mineralocorticoid receptor transcriptional activity through the protein kinase C \u03b2 signaling. Int Heart J. 2017, 58:794-802. 10.1536\/ihj.16-649","journal-title":"Int Heart J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2010.10.029","article-title":"Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats","volume":"8","author":"Kume O","year":"2011","unstructured":"Kume O, Takahashi N, Wakisaka O, et al.. Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats. Heart Rhythm. 2011, 8:278-85. 10.1016\/j.hrthm.2010.10.029","journal-title":"Heart Rhythm"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0860","article-title":"Development of a panel of monoclonal antibodies against the mineralocorticoid receptor","volume":"147","author":"Gomez-Sanchez CE","year":"2006","unstructured":"Gomez-Sanchez CE, de Rodriguez AF, Romero DG, Estess J, Warden MP, Gomez-Sanchez MT, Gomez-Sanchez EP. Development of a panel of monoclonal antibodies against the mineralocorticoid receptor. Endocrinology. 2006, 147:1343-8. 10.1210\/en.2005-0860","journal-title":"Endocrinology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.539122","article-title":"Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria","volume":"112","author":"Quinkler M","year":"2005","unstructured":"Quinkler M, Zehnder D, Eardley KS, et al.. Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria. Circulation. 2005, 112:1435-43. 10.1161\/CIRCULATIONAHA.105.539122","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2018.01.007","article-title":"Epidermal growth factor receptor\/extracellular signal-regulated kinase pathway enhances mineralocorticoid receptor transcriptional activity through protein stabilization","volume":"473","author":"Mitsuishi Y","year":"2018","unstructured":"Mitsuishi Y, Shibata H, Kurihara I, et al.. Epidermal growth factor receptor\/extracellular signal-regulated kinase pathway enhances mineralocorticoid receptor transcriptional activity through protein stabilization. Mol Cell Endocrinol. 2018, 473:89-99. 10.1016\/j.mce.2018.01.007","journal-title":"Mol Cell Endocrinol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1879","article-title":"Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease","volume":"14","author":"Shibata S","year":"2008","unstructured":"Shibata S, Nagase M, Yoshida S, et al.. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med. 2008, 14:1370-6. 10.1038\/nm.1879","journal-title":"Nat Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams B","year":"2015","unstructured":"Williams B, MacDonald TM, Morant S, et al.. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial. Lancet. 2015, 386:2059-68. 10.1016\/S0140-6736(15)00257-3","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-024-01959-2","article-title":"Treatment with a mineralocorticoid receptor blocker esaxerenone on top of the first-line therapy: promise in uncontrolled hypertension","author":"Mukoyama M","year":"2024","unstructured":"Mukoyama M. Treatment with a mineralocorticoid receptor blocker esaxerenone on top of the first-line therapy: promise in uncontrolled hypertension. Hypertens Res. 2024, 10.1038\/s41440-024-01959-2","journal-title":"Hypertens Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-022-01036-6","article-title":"Mechanisms of mineralocorticoid receptor-associated hypertension in diabetes mellitus: the role of O-GlcNAc modification","volume":"46","author":"Jo R","year":"2023","unstructured":"Jo R, Shibata H, Kurihara I, et al.. Mechanisms of mineralocorticoid receptor-associated hypertension in diabetes mellitus: the role of O-GlcNAc modification. Hypertens Res. 2023, 46:19-31. 10.1038\/s41440-022-01036-6","journal-title":"Hypertens Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12080502","article-title":"Indoxyl sulfate contributes to adipose tissue inflammation through the activation of NADPH oxidase","volume":"12","author":"Tanaka S","year":"2020","unstructured":"Tanaka S, Watanabe H, Nakano T, et al.. Indoxyl sulfate contributes to adipose tissue inflammation through the activation of NADPH oxidase. Toxins (Basel). 2020, 12:10.3390\/toxins12080502","journal-title":"Toxins (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-022-02862-z","article-title":"Serum total indoxyl sulfate levels and all-cause and cardiovascular mortality in maintenance hemodialysis patients: a prospective cohort study","volume":"23","author":"Li Q","year":"2022","unstructured":"Li Q, Zhang S, Wu QJ, et al.. Serum total indoxyl sulfate levels and all-cause and cardiovascular mortality in maintenance hemodialysis patients: a prospective cohort study. BMC Nephrol. 2022, 23:231. 10.1186\/s12882-022-02862-z","journal-title":"BMC Nephrol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/toxins10050202","article-title":"Role of uremic toxins for kidney, cardiovascular, and bone dysfunction","volume":"10","author":"Fujii H","year":"2018","unstructured":"Fujii H, Goto S, Fukagawa M. Role of uremic toxins for kidney, cardiovascular, and bone dysfunction. Toxins (Basel). 2018, 10:10.3390\/toxins10050202","journal-title":"Toxins (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041896","article-title":"Oxidative stress-induced glomerular mineralocorticoid receptor activation limits the benefit of salt reduction in Dahl salt-sensitive rats","volume":"7","author":"Kitada K","year":"2012","unstructured":"Kitada K, Nakano D, Liu Y, et al.. Oxidative stress-induced glomerular mineralocorticoid receptor activation limits the benefit of salt reduction in Dahl salt-sensitive rats. PLoS One. 2012, 7:e41896. 10.1371\/journal.pone.0041896","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01131","article-title":"Finerenone attenuates endothelial dysfunction and albuminuria in a chronic kidney disease model by a reduction in oxidative stress","volume":"9","author":"Gonz\u00e1lez-Bl\u00e1zquez R","year":"2018","unstructured":"Gonz\u00e1lez-Bl\u00e1zquez R, Somoza B, Gil-Ortega M, et al.. Finerenone attenuates endothelial dysfunction and albuminuria in a chronic kidney disease model by a reduction in oxidative stress. Front Pharmacol. 2018, 9:1131. 10.3389\/fphar.2018.01131","journal-title":"Front Pharmacol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/nu15071732","article-title":"Renal-protective roles of lipoic acid in kidney disease","volume":"15","author":"Kamt SF","year":"2023","unstructured":"Kamt SF, Liu J, Yan LJ. Renal-protective roles of lipoic acid in kidney disease. Nutrients. 2023, 15:10.3390\/nu15071732","journal-title":"Nutrients"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.11.1773","article-title":"An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys","volume":"15","author":"Miyazaki T","year":"2000","unstructured":"Miyazaki T, Aoyama I, Ise M, Seo H, Niwa T. An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys. Nephrol Dial Transplant. 2000, 15:1773-81. 10.1093\/ndt\/15.11.1773","journal-title":"Nephrol Dial Transplant"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2013.05.009","article-title":"Aldosterone regulates Na(+), K(+) ATPase activity in human renal proximal tubule cells through mineralocorticoid receptor","volume":"1833","author":"Salyer SA","year":"2013","unstructured":"Salyer SA, Parks J, Barati MT, Lederer ED, Clark BJ, Klein JD, Khundmiri SJ. Aldosterone regulates Na(+), K(+) ATPase activity in human renal proximal tubule cells through mineralocorticoid receptor. Biochim Biophys Acta. 2013, 1833:2143-52. 10.1016\/j.bbamcr.2013.05.009","journal-title":"Biochim Biophys Acta"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-024-01734-3","article-title":"Mineralocorticoid receptor overactivation in diabetes mellitus: role of O-GlcNAc modification","volume":"47","author":"Jo R","year":"2024","unstructured":"Jo R, Itoh H, Shibata H. Mineralocorticoid receptor overactivation in diabetes mellitus: role of O-GlcNAc modification. Hypertens Res. 2024, 47:2126-32. 10.1038\/s41440-024-01734-3","journal-title":"Hypertens Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/toxins10090367","article-title":"Impacts of indoxyl sulfate and p-Cresol sulfate on chronic kidney disease and mitigating effects of AST-120","volume":"10","author":"Liu WC","year":"2018","unstructured":"Liu WC, Tomino Y, Lu KC.  Impacts of indoxyl sulfate and p-Cresol sulfate on chronic kidney disease and mitigating effects of AST-120. Toxins (Basel). 2018, 10:367. 10.3390\/toxins10090367","journal-title":"Toxins (Basel)"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris GL","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, et al..  Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med. 2020, 383:2219-29. 10.1056\/NEJMoa2025845","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt B","year":"2021","unstructured":"Pitt B, Filippatos G, Agarwal R, et al.. Cardiovascular events with finerenone in kidney disease and type 2 diabetes. N Engl J Med. 2021, 385:2252-63. 10.1056\/NEJMoa2110956","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.05.011","article-title":"Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial","volume":"54","author":"Akizawa T","year":"2009","unstructured":"Akizawa T, Asano Y, Morita S, et al.. Effect of a carbonaceous oral adsorbent on the progression of CKD: a multicenter, randomized, controlled trial. Am J Kidney Dis. 2009, 54:459-67. 10.1053\/j.ajkd.2009.05.011","journal-title":"Am J Kidney Dis"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014010042","article-title":"Randomized placebo-controlled EPPIC trials of ast-120 in CKD","volume":"26","author":"Schulman G","year":"2015","unstructured":"Schulman G, Berl T, Beck GJ, et al.. Randomized placebo-controlled EPPIC trials of ast-120 in CKD. J Am Soc Nephrol. 2015, 26:1732-46. 10.1681\/ASN.2014010042","journal-title":"J Am Soc Nephrol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-016-0357-9","article-title":"The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials","volume":"17","author":"Schulman G","year":"2016","unstructured":"Schulman G, Berl T, Beck GJ, et al.. The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials. BMC Nephrol. 2016, 17:141. 10.1186\/s12882-016-0357-9","journal-title":"BMC Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/316690-indoxyl-sulfate-and-its-potential-role-in-mineralocorticoid-receptor-transactivation-in-chronic-kidney-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T22:36:07Z","timestamp":1733524567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/316690-indoxyl-sulfate-and-its-potential-role-in-mineralocorticoid-receptor-transactivation-in-chronic-kidney-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":37,"URL":"https:\/\/doi.org\/10.7759\/cureus.75236","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,6]]}}}